Stay updated on Novel Vaccine Efficacy Clinical Trial
Sign up to get notified when there's something new on the Novel Vaccine Efficacy Clinical Trial page.

Latest updates to the Novel Vaccine Efficacy Clinical Trial page
- Check7 days agoChange DetectedThe record describes a Phase 2 study of ivacaftor for COPD with chronic bronchitis, including its eligibility criteria, treatment arms, and outcome measures. It is marked withdrawn because the study never started after the study drug’s availability changed.SummaryDifference41%

- Check14 days agoChange DetectedThe ClinicalTrials.gov footer now identifies the site revision as v3.8.0 instead of v3.7.2. The page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check21 days agoChange DetectedA banner announces an NIH terminology transition, saying that federal agencies are using “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI) during the transition.SummaryDifference1%

- Check28 days agoChange DetectedThe ClinicalTrials.gov page continues to display a 403 Forbidden error. Its footer now shows revision v3.7.2 instead of v3.7.1.SummaryDifference0.2%

- Check35 days agoChange DetectedThe site revision in the footer changed from v3.7.0 to v3.7.1, while the study page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check56 days agoChange DetectedThe study page now displays a 403 Forbidden error instead of study content, removing access to the trial's details and sections. The header and footer remain, but the main content is replaced by the error message.SummaryDifference17%

Stay in the know with updates to Novel Vaccine Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Novel Vaccine Efficacy Clinical Trial page.